Incidence and Severity of Neuropsychiatric Adverse Events of Efavirenz Given as a Stepped Dosage vs. the Usual Dosage

This study has been completed.

Sponsor:

Collaborator:

Consejeria de Salud. Junta de Andalucia. Spain

Information provided by:

Sociedad Andaluza de Enfermedades Infecciosas

ClinicalTrials.gov Identifier:

NCT00556634

First received: November 8, 2007

Last updated: January 14, 2009

Last verified: January 2009

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	January 2008
Primary Completion Date:	January 2008 (Final data collection date for primary outcome measure)

No publications provided by Sociedad Andaluza de Enfermedades Infecciosas

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Gutiérrez-Valencia A, Viciana P, Palacios R, Ruiz-Valderas R, Lozano F, Terrón A, Rivero A, López-Cortés LF; Sociedad Andaluza de Enfermedades Infecciosas. Stepped-dose versus full-dose efavirenz for HIV infection and neuropsychiatric adverse events: a randomized trial. Ann Intern Med. 2009 Aug 4;151(3):149-56. Epub 2009 Jul 6.

To Top